Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Philip

Showing results (411-420 of 441) with videos related to

Pageof 45
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
Does nephroblastomatosis influence the natural history and relapse rate in Wilms' tumour? A single centre experience over 11 yearsC Bergeron, C Iliescu, P Thiesse, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2003
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNSMohab M Ibrahim, Hongfeng Deng, Alexander Zvonok, et al.
British Journal of Cancer|March 5, 2002
A controlled "before-after" study: impact of a clinical guidelines programme and regional cancer network organization on medical practiceI Ray-Coquard, T Philip, G de Laroche, et al.
Pain|March 28, 2006
CB2 cannabinoid receptor mediation of antinociceptionMohab M Ibrahim, Megan L Rude, Nicola J Stagg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Société Française d'Oncologie PédiatriqueT Philip, C Iliescu, M C Demaille, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2005
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioidsMohab M Ibrahim, Frank Porreca, Josephine Lai, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 27, 2006
A meeting of minds: interdisciplinary research in the health sciences in CanadaJudith G Hall, Lesley Bainbridge, Alison Buchan, et al.
Pain|January 17, 2017
Long-lasting antinociceptive effects of green light in acute and chronic pain in ratsMohab M Ibrahim, Amol Patwardhan, Kerry B Gilbraith, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Tolerance evaluation of L-asparaginase loaded in red blood cellsR Kravtzoff, P H Colombat, I Desbois, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastomaJ M Michon, O Hartmann, E Bouffet, et al.
Pageof 45

Showing results (411-420 of 441) with videos related to

Sort By:
Pageof 45
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
Does nephroblastomatosis influence the natural history and relapse rate in Wilms' tumour? A single centre experience over 11 yearsC Bergeron, C Iliescu, P Thiesse, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2003
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNSMohab M Ibrahim, Hongfeng Deng, Alexander Zvonok, et al.
British Journal of Cancer|March 5, 2002
A controlled "before-after" study: impact of a clinical guidelines programme and regional cancer network organization on medical practiceI Ray-Coquard, T Philip, G de Laroche, et al.
Pain|March 28, 2006
CB2 cannabinoid receptor mediation of antinociceptionMohab M Ibrahim, Megan L Rude, Nicola J Stagg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Société Française d'Oncologie PédiatriqueT Philip, C Iliescu, M C Demaille, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2005
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioidsMohab M Ibrahim, Frank Porreca, Josephine Lai, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 27, 2006
A meeting of minds: interdisciplinary research in the health sciences in CanadaJudith G Hall, Lesley Bainbridge, Alison Buchan, et al.
Pain|January 17, 2017
Long-lasting antinociceptive effects of green light in acute and chronic pain in ratsMohab M Ibrahim, Amol Patwardhan, Kerry B Gilbraith, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Tolerance evaluation of L-asparaginase loaded in red blood cellsR Kravtzoff, P H Colombat, I Desbois, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastomaJ M Michon, O Hartmann, E Bouffet, et al.
Pageof 45